🚀 VC round data is live in beta, check it out!
Mindray Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mindray and similar public comparables like Fresenius, Agilent, Waters, GE HealthCare and more.
Mindray Overview
About Mindray
Shenzhen Mindray Bio-Medical Electronics Co Ltd is a developer, manufacturer, and supplier of medical devices. The company is focused on the medical industry in the fields of Patient Monitoring & Life Support, InVitro Diagnostics, and Medical Imaging.
Founded
1999
HQ
Employees
21.7K
Website
Financials (LTM)
EV
$30B
Mindray Financials
Mindray reported last 12-month revenue of $5B and EBITDA of $2B.
In the same LTM period, Mindray generated $3B in gross profit, $2B in EBITDA, and $1B in net income.
Revenue (LTM)
Mindray P&L
In the most recent fiscal year, Mindray reported revenue of $5B and EBITDA of $2B.
Mindray expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | XXX | $5B | XXX | XXX | XXX |
| Gross Profit | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 63% | XXX | XXX | XXX |
| EBITDA | $2B | XXX | $2B | XXX | XXX | XXX |
| EBITDA Margin | 35% | XXX | 40% | XXX | XXX | XXX |
| EBIT Margin | 32% | XXX | 36% | XXX | XXX | XXX |
| Net Profit | $1B | XXX | $2B | XXX | XXX | XXX |
| Net Margin | 28% | XXX | 32% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Mindray Stock Performance
Mindray has current market cap of $33B, and enterprise value of $30B.
Market Cap Evolution
Mindray's stock price is $26.92.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $30B | $33B | -0.1% | XXX | XXX | XXX | $1.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMindray Valuation Multiples
Mindray trades at 5.9x EV/Revenue multiple, and 17.1x EV/EBITDA.
EV / Revenue (LTM)
Mindray Financial Valuation Multiples
As of March 28, 2026, Mindray has market cap of $33B and EV of $30B.
Equity research analysts estimate Mindray's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mindray has a P/E ratio of 22.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $33B | XXX | $33B | XXX | XXX | XXX |
| EV (current) | $30B | XXX | $30B | XXX | XXX | XXX |
| EV/Revenue | 5.9x | XXX | 5.7x | XXX | XXX | XXX |
| EV/EBITDA | 17.1x | XXX | 14.4x | XXX | XXX | XXX |
| EV/EBIT | 18.8x | XXX | 15.9x | XXX | XXX | XXX |
| EV/Gross Profit | 9.7x | XXX | 9.0x | XXX | XXX | XXX |
| P/E | 22.6x | XXX | 19.3x | XXX | XXX | XXX |
| EV/FCF | 18.3x | XXX | 19.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mindray Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Mindray Margins & Growth Rates
Mindray's revenue in the last 12 month grew by 12%.
Mindray's revenue per employee in the last FY averaged $0.2M.
Mindray's rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mindray's rule of X is 63% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Mindray Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | (7%) | XXX | XXX | XXX |
| EBITDA Margin | 35% | XXX | 40% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | (18%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 46% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 63% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 15% | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 5% | XXX | 1% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 28% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Mindray Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fresenius | XXX | XXX | XXX | XXX | XXX | XXX |
| Agilent | XXX | XXX | XXX | XXX | XXX | XXX |
| Waters | XXX | XXX | XXX | XXX | XXX | XXX |
| GE HealthCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mindray M&A Activity
Mindray acquired XXX companies to date.
Last acquisition by Mindray was on XXXXXXXX, XXXXX. Mindray acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Mindray
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMindray Investment Activity
Mindray invested in XXX companies to date.
Mindray made its latest investment on XXXXXXXX, XXXXX. Mindray invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Mindray
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mindray
| When was Mindray founded? | Mindray was founded in 1999. |
| Where is Mindray headquartered? | Mindray is headquartered in China. |
| How many employees does Mindray have? | As of today, Mindray has over 21K employees. |
| Is Mindray publicly listed? | Yes, Mindray is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Mindray? | Mindray trades under 300760 ticker. |
| When did Mindray go public? | Mindray went public in 2018. |
| Who are competitors of Mindray? | Mindray main competitors are Fresenius, Agilent, Waters, GE HealthCare. |
| What is the current market cap of Mindray? | Mindray's current market cap is $33B. |
| What is the current revenue of Mindray? | Mindray's last 12 months revenue is $5B. |
| What is the current revenue growth of Mindray? | Mindray revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Mindray? | Current revenue multiple of Mindray is 5.9x. |
| Is Mindray profitable? | Yes, Mindray is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Mindray? | Mindray's last 12 months EBITDA is $2B. |
| What is Mindray's EBITDA margin? | Mindray's last 12 months EBITDA margin is 35%. |
| What is the current EV/EBITDA multiple of Mindray? | Current EBITDA multiple of Mindray is 17.1x. |
| What is the current FCF of Mindray? | Mindray's last 12 months FCF is $2B. |
| What is Mindray's FCF margin? | Mindray's last 12 months FCF margin is 32%. |
| What is the current EV/FCF multiple of Mindray? | Current FCF multiple of Mindray is 18.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.